In the Lab

Putting the latest life science research under the microscope: Our latest and most-read topics range from breast cancer to sickle cell anemia, Ehlers-Danlos syndrome to gene editing, HPV vaccines to obesity. These are the medical discoveries that can drive corporate strategy, money and market share in the life sciences industry.

Health Allison Bond

Why fentanyl is deadlier than heroin, in a single photo

Fentanyl is up to 100 times more potent than morphine and many times that of heroin. Drug users generally don’t know when their heroin is laced with fentanyl, so when they inject their usual quantity of heroin, they can inadvertently take a deadly dose of the substance. Read more from STAT.

Read The Story

In the Lab Megan Molteni

Human ‘pangenome’ published, with goal of making genomics more useful for diverse populations

In the Lab Sharon Begley

‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims — and finding some truth

In the Lab Jessica Bartlett — Boston Globe

STAT Plus: Brigham creates institute focused on immunology with record $100 million gift

Biotech Jason Mast

STAT Plus: Gene therapy has helped boys like Conner walk. Scientists are trying to keep it that way

All Coverage

Biotech Jason Mast

STAT Plus: Genentech review of Tessier-Lavigne paper finds no evidence of fraud — but hints at a different misconduct case

Special Report Jonathan Wosen

In the Lab

Why fentanyl is deadlier than heroin, in a single photo

Human ‘pangenome’ published, with goal of making genomics more useful for diverse populations

‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims — and finding some truth

STAT Plus: Brigham creates institute focused on immunology with record $100 million gift

STAT Plus: Gene therapy has helped boys like Conner walk. Scientists are trying to keep it that way

All Coverage

STAT Plus: Doudna talks cost, access issues looming over first CRISPR therapy

An MRI helmet out of ‘Back to the Future’ wins STAT Summit research pick

Don’t ignore potential microbial causes of Alzheimer’s and other chronic diseases, researchers say

Expansive investigation into Stanford president’s past research will be ‘substantially complete’ by mid-July

STAT Wunderkinds discuss high-impact research, resilience, and social justice

Vast sequencing project begins to unlock human genome’s secrets — by deciphering other mammals’ DNA

STAT Plus: Early findings in gene therapy death suggest CRISPR was not the cause

Stock drama, cancer vaccine success, and new science — highlights from AACR

FDA’s new plan to study opioids’ effectiveness faces resistance

Discrimination lawsuit against HHMI spotlights barriers faced by scientists with disabilities

STAT Plus: Novel strategy of attacking sugars on cancer cells to free immune system shows promise in early tests

STAT Plus: Why do some blood stem cells go rogue? Study offers clue and possible target

Scientists, going on a bear hunt, find a potential way to treat deadly blood clots

STAT Plus: ‘It was my call’: Stanford president defends decision not to correct key paper in misconduct investigation

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

STAT Plus: Genentech review of Tessier-Lavigne paper finds no evidence of fraud — but hints at a different misconduct case

STAT Plus: Research misconduct allegations put Stanford’s president — and science — under an uncomfortable spotlight

In the whitewashed world of Alzheimer’s research, one scientist is on a quest to understand the diversity of brains

STAT Plus: New research may give geneticists a long-sought tool: a targeted protein delivery device

A half century after Prozac, a new generation of depression drugs is bringing hope to a long-stagnant field

STAT Plus: Researchers devise new strategies to overcome a key CRISPR flaw

‘That is my dream’: Scientist who uncovered likely leading cause of MS wants to tackle ALS next

National Academies calls for transforming use of racial and ethnic labels in genetics research

Setting aside the thorniest issues around CRISPR babies, scientists say embryo-editing research should proceed

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day

Subscribe to STAT+ for less than $2 per day

Become a STAT+ subscriber today!

In the Lab

Your daily dose of news in health and medicine Sign Up

All Coverage

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day

Subscribe to STAT+ for less than $2 per day

Become a STAT+ subscriber today!